Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment

about

Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment

Item

http://www.wikidata.org/entity/Q59136527

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Regression of primary cardiac ...... ol as a single agent treatment

@en

Regression of primary cardiac ...... ol as a single agent treatment

@nl

type

Item

label

Regression of primary cardiac ...... ol as a single agent treatment

@en

Regression of primary cardiac ...... ol as a single agent treatment

@nl

prefLabel

Regression of primary cardiac ...... ol as a single agent treatment

@en

Regression of primary cardiac ...... ol as a single agent treatment

@nl

P1476

Regression of primary cardiac ...... ol as a single agent treatment

@en

P2093

Anoop P Ayyappan

http://www.w3.org/2001/XMLSchema#string

Brad A Bryan

http://www.w3.org/2001/XMLSchema#string

Dana C Galván

http://www.w3.org/2001/XMLSchema#string

P2860

Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease

Successful Propranolol Treatment of a Kaposiform Hemangioendothelioma Apparently Resistant to Propranolol.

Cardiac angiosarcoma: two cases and a review of the literature.

Primary cardiac sarcoma.

Propranolol Decreases Proliferation of Endothelial Cells Transformed by Kaposi's Sarcoma-Associated Herpesvirus and Induces Lytic Viral Gene Expression.

Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.

A randomized, controlled trial of oral propranolol in infantile hemangioma.

Perivascular epithelioid cell neoplasms: pathology and pathogenesis.

Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.

A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.

P304

264-268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOSCIENCE.472

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

9-10

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30460329

http://www.w3.org/2001/XMLSchema#string

P932

6231448

http://www.w3.org/2001/XMLSchema#string